News

Blog

Ali Azhdarinia, PhD, Recognized by AACR for NETRF-Funded Research

The American Association for Cancer Research recently recognized the NETRF-funded research of Ali Azhdarinia, PhD, of the University of Texas Health Science Center at Houston. Dr. Azhdarinia is investigating image-guided precision medicine to treat NETs in the gastrointestinal tract and pancreas that are resistant to chemotherapy.

Read More »
Blog

NETRF Welcomes Two New Members to its Board of Scientific Advisors

The Neuroendocrine Tumor Research Foundation (NETRF) is pleased to welcome Dr. Matthew H. Kulke and Dr. Daniel M. Halperin to its Board of Scientific Advisors (BOSA), a volunteer council of highly distinguished medical and research leaders who share NETRF’s commitment to advancing the understanding, diagnosis, and treatment of neuroendocrine cancer. Although these renowned physicians may be new to the BOSA, they are not new to NETs or NETRF. In fact, they are both recognized as leading experts worldwide for their care of NET patients and research.

Read More »